Choosing Breast Cancer Risk Models: Importance of Independent Validation

被引：10
|
作者：
Gail, Mitchel H. [1 ]
机构：
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2020年 / 112卷 / 05期
基金：
美国国家卫生研究院;
关键词：
WOMEN; SUSCEPTIBILITY; PROBABILITIES; PREVENTION; TAMOXIFEN;
D O I：
10.1093/jnci/djz180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：433 / 435
页数：3
相关论文
共 50 条
  • [1] Risk Models for Breast Cancer and Their Validation
    Brentnall, Adam R.
    Cuzick, Jack
    STATISTICAL SCIENCE, 2020, 35 (01) : 14 - 30
  • [2] Independent evaluation and validation of mammography-based breast cancer risk models in a diverse patient cohort
    Omoleye, Olasubomi J.
    Woodard, Anna
    Zhao, Fangyuan
    Levental, Maksim
    Yoshimatsu, Toshio F.
    Zheng, Yonglan
    Olopade, Olufunmilayo I.
    Huo, Dezheng
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Independent validation of the Breast Cancer Risk Assessment Tool (Gail model) for predicting breast cancer risk in Egyptian population
    Yacoub, E. T. T.
    Mohammed, M.
    Abdelaziz, A. H.
    Shash, E.
    ElGhazawy, H.
    Hussein, N.
    Amin, H. M.
    El Ghazaly, H. A.
    Shafik, I.
    Shohdy, K. S.
    Kassem, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S946 - S946
  • [4] Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
    Cintolo-Gonzalez, Jessica A.
    Braun, Danielle
    Blackford, Amanda L.
    Mazzola, Emanuele
    Acar, Ahmet
    Plichta, Jennifer K.
    Griffin, Molly
    Hughes, Kevin S.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (02) : 263 - 284
  • [5] Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
    Jessica A. Cintolo-Gonzalez
    Danielle Braun
    Amanda L. Blackford
    Emanuele Mazzola
    Ahmet Acar
    Jennifer K. Plichta
    Molly Griffin
    Kevin S. Hughes
    Breast Cancer Research and Treatment, 2017, 164 : 263 - 284
  • [6] Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification
    Choudhury, Parichoy Pal
    Wilcox, Amber N.
    Brook, Mark N.
    Zhang, Yan
    Ahearn, Thomas
    Orr, Nick
    Coulson, Penny
    Schoemaker, Minouk J.
    Jones, Michael E.
    Gail, Mitchell H.
    Swerdlow, Anthony J.
    Chatterjee, Nilanjan
    Garcia-Closas, Montserrat
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (03): : 278 - 285
  • [7] Validation of breast cancer prognostic models
    Ribelles, N
    Barnadas, A
    Lopez, D
    Vaquero, M
    Rosell, R
    Sanchez, JJ
    ONCOLOGY REPORTS, 1997, 4 (02) : 419 - 423
  • [8] Erratum to: Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
    Jessica A. Cintolo-Gonzalez
    Danielle Braun
    Amanda L. Blackford
    Emanuele Mazzola
    Ahmet Acar
    Jennifer K. Plichta
    Molly Griffin
    Kevin S. Hughes
    Breast Cancer Research and Treatment, 2017, 164 : 745 - 745
  • [9] Validation of two US breast cancer risk prediction models in German women
    Huesing, Anika
    Quante, Anne S.
    Chang-Claude, Jenny
    Aleksandrova, Krasimira
    Kaaks, Rudolf
    Pfeiffer, Ruth M.
    CANCER CAUSES & CONTROL, 2020, 31 (06) : 525 - 536
  • [10] Validation of Risk Assessment Models for Predicting the Incidence of Breast Cancer in Korean Women
    Min, Jun Won
    Chang, Myung-Chul
    Lee, Hae Kyung
    Hur, Min Hee
    Noh, Dong-Young
    Yoon, Jung Han
    Jung, Yongsik
    Yang, Jung-Hyun
    JOURNAL OF BREAST CANCER, 2014, 17 (03) : 226 - 235
12345